Accelerated Technologies Partners (ATP) is an investment partnership that focuses on medical devices.
Accelerated Technologies Partners (“ATPâ€) is an investment partnership that focuses on medical devices and actively leverages a structured collaboration between world-leading physicians, experienced operational management and dedicated capital to produce superior returns and substantial clinical value. By aligning the interests and harnessing the collective resources of physicians, management and investors from inception through exit, the ATP strategy supports the acceleration of product development and lowers market and execution risks, enhancing capital efficiency and improving the likelihood of outstanding returns.
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
---|---|---|---|---|
Mar 23, 2009
Claros Diagnostics
|
Series B | $4M | Genetics | — |
Jan 19, 2007
Claros Diagnostics
|
Series A | $7.80M | Genetics | — |
Jun 30, 2006
Mitralign
|
Series B | $13M | Health Care | — |
Jun 8, 2005
Mitralign
|
Series Unknown | $6.70M | Health Care | — |
May 10, 2004
Mitralign
|
Series A | $3.50M | Health Care | — |
Accelerated Technologies Partners has had 3 exits. Accelerated Technologies Partners most notable exits include Mitralign , Claros Diagnostics
Date | Company Name | Exit Type | Industry | |
---|---|---|---|---|
Mar 11, 2019 | Mitralign | M&A | Health Care | Detail |
Oct 13, 2011 | Claros Diagnostics | M&A | Genetics | Detail |
Apr 28, 2005 | Impella Cardiosystems | M&A | Biotechnology | Detail |